NUMANS (02530) announced its annual results for the period ended December 31, 2025. The group recorded revenue of 189 million yuan, a decrease of 31.77% compared to the previous year. Profit for the year was 5.503 million yuan, reflecting a significant decline of 92.65%. Earnings per share stood at 0.55 fen, and the board has recommended a final dividend of 2.5 HK cents per share. Looking ahead, the group is actively expanding its product portfolio to reach a broader consumer base. Specifically, it has commenced development of a completely new product line targeting children aged 6 to 16, moving beyond its original focus on maternal and infant nutrition. Furthermore, the group continues to diversify its product offerings for lower-tier markets by introducing competitively priced, high-quality algae oil DHA products utilizing raw materials imported from France. These strategic initiatives, coupled with the group's ongoing investment in optimizing both online and offline distribution channels, are expected to strengthen its market position and support sustained, steady revenue growth in the medium term. The company has applied to the Stock Exchange for the resumption of trading of its shares, which will commence at 9:00 a.m. on May 4, 2026.